U.S Physical Therapy Income Taxes 2010-2025 | USPH

U.S Physical Therapy income taxes from 2010 to 2025. Income taxes can be defined as the total amount of income tax expense for the given period.
U.S Physical Therapy Annual Income Taxes
(Millions of US $)
2024 $15
2023 $12
2022 $12
2021 $15
2020 $13
2019 $14
2018 $11
2017 $6
2016 $12
2015 $14
2014 $13
2013 $12
2012 $11
2011 $10
2010 $9
2009 $8
U.S Physical Therapy Quarterly Income Taxes
(Millions of US $)
2025-03-31 $4
2024-12-31 $6
2024-09-30 $3
2024-06-30 $3
2024-03-31 $3
2023-12-31 $1
2023-09-30 $4
2023-06-30 $4
2023-03-31 $3
2022-12-31 $1
2022-09-30 $3
2022-06-30 $4
2022-03-31 $3
2021-12-31 $4
2021-09-30 $4
2021-06-30 $5
2021-03-31 $3
2020-12-31 $5
2020-09-30 $4
2020-06-30 $4
2020-03-31 $0
2019-12-31 $2
2019-09-30 $3
2019-06-30 $5
2019-03-31 $3
2018-12-31 $3
2018-09-30 $3
2018-06-30 $3
2018-03-31 $2
2017-12-31 $-2
2017-09-30 $3
2017-06-30 $3
2017-03-31 $2
2016-12-31 $3
2016-09-30 $3
2016-06-30 $4
2016-03-31 $2
2015-12-31 $3
2015-09-30 $4
2015-06-30 $4
2015-03-31 $3
2014-12-31 $2
2014-09-30 $4
2014-06-30 $4
2014-03-31 $3
2013-12-31 $3
2013-09-30 $3
2013-06-30 $3
2013-03-31 $2
2012-12-31 $2
2012-09-30 $3
2012-06-30 $3
2012-03-31 $3
2011-12-31 $1
2011-09-30 $3
2011-06-30 $3
2011-03-31 $2
2010-12-31 $1
2010-09-30 $3
2010-06-30 $3
2010-03-31 $2
2009-12-31 $2
2009-09-30 $2
2009-06-30 $2
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.201B $0.671B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.852B 19.56
Encompass Health (EHC) United States $12.317B 26.11
DaVita (DVA) United States $10.696B 15.04
Chemed (CHE) United States $8.183B 25.72
Elanco Animal Health (ELAN) United States $7.097B 15.20
Option Care Health (OPCH) United States $5.281B 23.54
RadNet (RDNT) United States $4.286B 272.00
Amedisys (AMED) United States $3.214B 21.62
Addus HomeCare (ADUS) United States $2.118B 23.26
LifeStance Health (LFST) United States $2.003B 0.00
Astrana Health (ASTH) United States $1.386B 34.35
Pennant (PNTG) United States $1.027B 37.72
Aveanna Healthcare Holdings (AVAH) United States $0.979B 55.78
Atai Life Sciences (ATAI) Germany $0.441B 0.00
Daxor (DXR) United States $0.044B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00